
Company valuation, historical trends, and peer comparisons.
According to Q32 Bio Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 161.15M. This represents a change of 377.21% compared to the average of 33.77M of the last 4 quarters.
The mean historical Enterprise Value of Q32 Bio Inc. over the last ten years is 416.89M. The current 161.15M Enterprise Value has changed -61.35% with respect to the historical average. Over the past ten years (40 quarters), QTTB's Enterprise Value was at its highest in in the March 2019 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2022 quarter at -50012921.60.
Average
416.89M
Median
458.27M
Minimum
-27000159.04
Maximum
818.06M
Discovering the peaks and valleys of Q32 Bio Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.39%
Maximum Annual Enterprise Value = 818.06M
Minimum Annual Increase = -129.20%
Minimum Annual Enterprise Value = -27000159.04
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 7.88M | -129.20% |
| 2024 | -27000159.04 | -117.34% |
| 2023 | 155.73M | -41.57% |
| 2022 | 266.52M | -61.77% |
| 2021 | 697.17M | 120.39% |
| 2020 | 316.34M | -61.33% |
| 2019 | 818.06M | 36.30% |
| 2018 | 600.20M | -7.22% |
| 2017 | 646.88M | -5.85% |
The current Enterprise Value of Q32 Bio Inc. (QTTB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
45.54M
5-year avg
220.06M
10-year avg
416.89M
Q32 Bio Inc.’s Enterprise Value is greater than NextCure, Inc. (16.95M), greater than Boundless Bio, Inc. (36.66M), less than SAB Biotherapeutics, Inc. (299.39M), greater than AN2 Therapeutics, Inc. (125.50M), greater than Verrica Pharmaceuticals Inc. (49.71M), greater than Plus Therapeutics, Inc. (11.19M), greater than Generation Bio Co. (40.14M), greater than Intensity Therapeutics, Inc. (-1158.00), greater than Iterum Therapeutics plc (25.39M), greater than Sonnet BioTherapeutics Holdings, Inc. (3.36M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 16.95M | $27.92M | |
| 36.66M | $56.87M | |
| 299.39M | $302.53M | |
| 125.50M | $169.81M | |
| 49.71M | $59.10M | |
| 11.19M | $9.36M | |
| 40.14M | $35.98M | |
| -1158.00 | $9.43M | |
| 25.39M | $1.60M | |
| 3.36M | $8.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q32 Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Q32 Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Q32 Bio Inc.'s Enterprise Value?
What is the highest Enterprise Value for Q32 Bio Inc. (QTTB)?
What is the 3-year average Enterprise Value for Q32 Bio Inc. (QTTB)?
What is the 5-year average Enterprise Value for Q32 Bio Inc. (QTTB)?
How does the current Enterprise Value for Q32 Bio Inc. (QTTB) compare to its historical average?